Kyung Hee Medical Center Develops Korea's First Digital Therapeutics Platform

Medical Information Systems and Data Integration
"Enables Patient-Centered Management"

Kyung Hee Medical Center has embarked on expanding the digital healthcare sector by establishing a platform to activate digital therapeutics (DTx).

Exterior view of Kyung Hee Medical Center. [Photo by Kyung Hee Medical Center]

On the 29th, Kyung Hee Medical Center announced that it has completed the construction of the country's first standard platform based on cloud and next-generation transmission technology standards (FHIR) servers to promote digital therapeutics.

The platform-based design allows for rapid and low-cost adaptation of digital therapeutics with various characteristics across different disease areas to hospital information systems, Kyung Hee Medical Center explained. Currently, the intellectual property rights of the related system are held by ODEN, and it plans to utilize the platform for confirmatory clinical research of 'DTx_E66,' a digital therapeutic for endocrine metabolic diseases under development in the first half of this year.

Lee Sang-yeol, CEO of ODEN and Director of Kyung Hee Digital Health Center as well as a professor at Kyung Hee University Hospital, said, "We aimed to overcome the limitations of information recognition and pursue patient convenience by making a platform that prescribes digital therapeutics to patients interoperable with hospital information systems, just as doctors prescribe medicine." He added, "Through this platform developed via academic and industry collaboration, we hope many patients visiting Kyung Hee Medical Center can easily and conveniently access the latest digital therapeutics-based medical services."

With the completion of the platform, Kyung Hee Medical Center plans to quickly introduce and apply the latest digital therapeutics through connections with major domestic and international digital therapeutics developers. In particular, ODEN and Peace Eyes will distribute the developed platform to major medical institutions at home and abroad to expand the digital therapeutics-based medical field.

Meanwhile, the platform construction involved Kyung Hee Medical Center's IT team (Team Leader Kim Jeong-ho), Peace Eyes (Executive Director Jeong Tae-geon), Hurei Positive (CEO Choi Du-a), and ODEN (CEO Lee Sang-yeol, professor of endocrinology at Kyung Hee University Hospital).

Service flowchart based on the digital therapeutics standard platform. [Image provided by Kyung Hee Medical Center]

This content was produced with the assistance of AI translation services.